Donald Hayden is an angel investor. He serves as a Senior Advisor at Prospect Venture Partners. He served as the Chairman at Nora Therapeutics. He brings to Prospect the experiences and perspective resulting from a highly-successful 25 year career with Bristol-Myers Squibb Company as well as the insights gained from key roles at a number of smaller, more entrepreneurial pharmaceutical and biotech companies over the past 5 years. At Bristol-Myers Squibb, Hayden served as President of Global Pharmaceuticals